Combating Doxorubicin-Resistant Acute Myeloid Leukemia
May 23, 2024
In this new study, researchers examined the impact of MIA-602 as monotherapy and in combination with Doxorubicin on three Doxorubicin-resistant acute myeloid leukemia cell lines. continue reading »